PetIQ, Inc.
$30.98-0.03%($-0.01)
TickerSpark Score
78/100
50
Valuation
75
Profitability
95
Growth
72
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PETQ research report →
52-Week Range99% of range
Low $15.09
Current $30.98
High $31.06
Companypetiq.com
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services.
- CEO
- McCord Christensen
- IPO
- 2017
- Employees
- 1,121
- HQ
- Eagle, ID, US
Price Chart
+66.47% · this period
Valuation
- Market Cap
- $919.17M
- P/E
- 423.56
- P/S
- 0.83
- P/B
- 4.08
- EV/EBITDA
- 15.69
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.94%
- Op Margin
- 5.45%
- Net Margin
- 0.19%
- ROE
- 0.99%
- ROIC
- 8.54%
Growth & Income
- Revenue
- $1.10B · 19.58%
- Net Income
- $2.13M · 104.38%
- EPS
- $0.07 · 104.38%
- Op Income
- $60.02M
- FCF YoY
- 46.30%
Performance & Tape
- 52W High
- $31.06
- 52W Low
- $15.09
- 50D MA
- $30.71
- 200D MA
- $22.28
- Beta
- 1.74
- Avg Volume
- 884.43K
Get TickerSpark's AI analysis on PETQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 24, 24 | Glasman Zvi | other | 21,268 |
| Oct 25, 24 | Glasman Zvi | sell | 36,513 |
| Oct 25, 24 | Glasman Zvi | sell | 21,268 |
| Oct 25, 24 | Glasman Zvi | sell | 16,000 |
| Oct 25, 24 | Huff Scott | sell | 4,103 |
| Oct 25, 24 | Huff Scott | sell | 6,077 |
| Oct 24, 24 | Lyon Chad D. | other | 13,985 |
| Oct 25, 24 | Lyon Chad D. | sell | 178 |
| Oct 25, 24 | Lyon Chad D. | sell | 6,311 |
| Oct 25, 24 | Lyon Chad D. | sell | 10,987 |
Our PETQ Coverage
We haven't published any research on PETQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PETQ Report →Similar Companies
ALBO+0.00%
Albireo Pharma, Inc.
$44.15
PSTX+0.00%
Poseida Therapeutics, Inc.
$9.50
ATRI+0.06%
Atrion Corporation
$459.92
HARP+0.09%
Harpoon Therapeutics, Inc.
$23.01
GRCL+0.05%
Gracell Biotechnologies Inc.
$10.25
VERV+0.27%
Verve Therapeutics, Inc.
$11.13
CSII+0.15%
Cardiovascular Systems, Inc.
$20.00
CBIO+2.33%
Crescent Biopharma, Inc.
$18.91